Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Hazard Ratio
Bias in Epidemiological Studies
Strategies for Assessing and Addressing Confounding
Hazard Rate
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 2, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Makoto M Jones1, Richard E Nelson1, Michael A Rubin1
1Veterans Affairs Salt Lake City Health Care System and the Department of Internal Medicine,University of Utah,Salt Lake City,Utah.
No abstract available in PubMed .